Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

RFA-NS-21-020: Research Program Award (R35 Clinical Trial Optional)

Closed Closed July 13, 2021 Opportunity RFA-NS-21-020

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2021.

National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make about 30 awards worth $20.0 million in total. Applications closed on July 13, 2021.

From the official notice on Grants.gov, last changed May 6, 2021. Checked November 7, 2026.

About this NIH notice

Projects funded under RFA-NS-21-020 were run by National Institute of Neurological Disorders and Stroke (NINDS, 9 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read RFA-NS-21-020 in the NIH Guide.

Other notices with this title

National Institutes of Health has posted this title under other numbers: earlier or later rounds, or the same competition for another area. Each has its own dates and may change its rules.

NoticePostedDeadlineStatus
RFA-NS-22-038April 1, 2022Closed July 15, 2024Closed

Key dates

PostedMay 6, 2021
DeadlineJuly 13, 2021
Archived by Grants.govAugust 18, 2021

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support and increased freedom and flexibility to Program Directors (PDs)/Principal Investigators (PIs) to allow them to redirect their time away from the administrative burden of writing and managing multiple grant applications and towards engaging in the lab. This RPA affords investigators at most career stages the opportunity to advance their long-term research goals, rigorously explore exciting research opportunities, and mentor trainees, which support and align with the mission of NINDS. RPAs will support the overall research programs of NINDS-funded investigators for up to 8 years, at a level commensurate with a PD/PIs recent NINDS support (Part 2, Section II). This greater funding stability will provide eligible investigators increased security, allowing them to undertake research projects that require a longer timeframe or to embark upon research that breaks new ground. Research activities outside of the NINDS mission, or traditionally supported by another NIH Institute or Center, will not be considered through this program.

Category: Health.

Funded under RFA-NS-21-020 so far

NIH funded 9 projects under RFA-NS-21-020 in fiscal 2022 to 2026, at 9 institutions. The median yearly award was $862,680.

Recently funded projects
ProjectInstitutionFiscal yearAward
Molecular genetics of axon and synapse development and maintenance R35University of California, San Diego2026$862,680
Fusion pores in endocrine and synaptic exocytosis R35University of Wisconsin-Madison2026$1.0 million
Ataxin-2 complex proteins in neurodegeneration. R35Utah State Higher Education System--University of Utah2026$930,250
Development, Maintenance, and Human-Specific Evolution of Cortical Circuits R35Columbia University Health Sciences2026$1.2 million
Molecular genetics of neurodegenerative pathogenic and protective pathways: The SCA1 perspective R35University of Minnesota2026$848,662
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntington’s Disease R35Massachusetts Institute of Technology2026$542,850
Ion Channel Pharmacology for Pain and Epilepsy R35Harvard Medical School2026$1.1 million
Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity R35Pennsylvania State Univ Hershey Med Ctr2026$896,585

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Extramural Research Programs in the Neurosciences and Neurological Disorders grants before

From fiscal 2021 to 2025, Extramural Research Programs in the Neurosciences and Neurological Disorders (93.853) awarded $9.1 billion across 8,641 grant awards, an average of $1.0 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
The General Hospital CorporationMassachusetts203$288 million
The Regents of the University of California, San FranciscoCalifornia248$277 million
The Johns Hopkins UniversityMaryland230$276 million
The Trustees of Columbia University in the City of New YorkNew York188$226 million
Regents of the University of MichiganMichigan179$221 million

Top states: California ($1.4 billion), New York ($926 million), Massachusetts ($906 million), Pennsylvania ($626 million), Texas ($499 million).

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-NS-21-020 still open?

No. It closed on July 13, 2021.

Who can apply for Research Program Award (R35 Clinical Trial Optional)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for Research Program Award (R35 Clinical Trial Optional)?

Closed July 13, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

About $20.0 million in total across about 30 awards.

Who has been funded under RFA-NS-21-020?

NIH RePORTER lists 9 projects funded under RFA-NS-21-020 in fiscal 2022 to 2026, at 9 institutions. The most were at University of California, San Diego, University of Wisconsin-Madison, Utah State Higher Education System--University of Utah.

Who has won Extramural Research Programs in the Neurosciences and Neurological Disorders grants before?

The largest recipients over five fiscal years were The General Hospital Corporation, The Regents of the University of California, San Francisco, The Johns Hopkins University. The program made 8,641 awards worth $9.1 billion in that time.

Similar open grants